Product liability legislation
This article was originally published in The Gray Sheet
Executive Summary
The Senate Judiciary Committee will vote on S 687 March 24, according to Sen. Howell Heflin's (D-Ala.) office. The bill, which passed the Senate Commerce Committee by a vote of 16-4 in November ("The Gray Sheet" Nov. 15, 1993, p. 30), is expected to reach the Senate floor by April 11. The Judiciary/Courts Subcommittee held a hearing on the bill on March 15. Although similar legislation has been defeated several times in the past, S 687's supporters are optimistic about the bill's chances of passing this year. One former opponent who has changed his mind is Sen. David Pryor (D- Ark.)
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.